Keyword: emerging markets

Chemistry & Life Sciences

A Lever For Growth

03.06.2013 - New Markets, New Approaches - Opportunity still abounds for chemical distributors to win more business, as chemical producers look to them to provide ever more sophisticated and...

News

Unilever to Raise Stake in Indian Unit in $5.4 Billion Offer

30.04.2013 - Anglo-Dutch consumer goods giant Unilever will pay as much as $5.4 billion to raise its stake in its Indian unit, Hindustan Unilever, to up to 75% in a bet on fast-growing spending...

News

Schott Expands Footprint in "Pharmerging" Markets with Investment in Indonesia

09.03.2013 - Schott Pharmaceutical Systems announced today its plans to expand its overall production capacities at its plant in Bekasi, Indonesia, by 20%. With this strategic move, the company...

News

Eli Lilly to Pay $29 Million to Settle US SEC Bribery Case

21.12.2012 - U.S. drugmaker Eli Lilly agreed on Thursday to pay $29 million to settle civil charges that its subsidiaries made improper payments to foreign government officials to win business...

News

China Top Target for Record Pharma Emerging Market M&A

12.12.2012 - Drug companies are spending record amounts on acquisitions in emerging markets, with China the most attractive target nation, reflecting sharply rising sales of western medicines...

News

GSK and J&J Lead Rivals in Drug Access for Poor

28.11.2012 - Drugmakers - led by GlaxoSmithKline and Johnson & Johnson - are stepping up efforts to ensure their medicines are available and affordable in poor countries, after being attacked...

News

Cipla to Bid $215 Million for Control of South Africa Affiliate

21.11.2012 - Indian drugmaker Cipla plans to offer $215 million for a majority stake in South Africa's Cipla Medpro to strengthen its presence in Africa's fast-growing market for cheap, generic...

News

Pfizer Quarterly Revenue Fall Far Short of Forecasts

01.11.2012 - Pfizer reported on Thursday quarterly revenue well below Wall Street expectations, on sharply weaker sales of specialty care drugs and a pullback of emerging market revenue...